Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2026-09-22 21:00:18 ET · period of report 2026-09-20 · accession 0001140361-26-037363 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-22 21:00 | 2026-09-20 | ROIV | Humes Jennifer | CAO | F - Tax | $39.77 | -3,880 | 106.4K | -4% | -$154.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-09-20 | F | D | 3,880 | $39.77 | 106,419 | D | — | — | (F1) Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. (F2) Includes Common Shares purchased under the Company's Employee Stock Purchase Plan. |